ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

NCI RFA: Basic Biobehavioral Research

August 6, 1999

Ethics rules slammed by NIH scientists, institute directors, societies, Senators.

April 8, 2005

Carlson Named NCCN Chief Executive

September 28, 2012

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI

April 22, 1994

NCI To End CIS Partnership Program In 2010.

December 5, 2008